Saturday, 7 November 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 28, 2026

Crypto News Today: Pepeto Project News While Bull Run Signals Align and Dogecoin SEC Commodity Ruling Opens the Door for What Comes Next

View original at globenewswire.com
Crypto News Today: Pepeto Project News While Bull Run Signals Align and Dogecoin SEC Commodity Ruling Opens the Door for What Comes Next Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto pushed past $8.47 million after its latest round closed ahead of schedule while the crypto news today delivered the catalysts thi…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Binance long ratio on Dogecoin flipped bullish for the first time in months

    60% confidence

  • Pepeto presale rounds close faster every week

    60% confidence

  • Binance listing is happening in the few days comings

    60% confidence

  • Analyst targets for Dogecoin in this bull run sit between $0.20 and $0.47, a respectable 2x to 5x for holders

    60% confidence

  • Pepeto organic growth is already outpacing what the team expected

    60% confidence

  • Dogecoin reached $85 billion market cap on community alone and then lost 93% because there was nothing generating demand once the attention moved on

    60% confidence

  • Active wallet addresses jumped 176% in one week

    60% confidence

Data points we hold from this source

Pepeto · funds raised8.47 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com
Crypto News Today: Pepeto Project News While Bull Run Signals Align and Dogecoin SEC Commodity Ruling Opens the Door for What Comes Next — Source | Via News | ViaNews EU